BE ATC L01CD02 · updated 2 Nov 2026
Docetaxel shortage in Belgium
Is there a Docetaxel shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Docetaxel products are reported short in Belgium, the first since 22 May 2026. The company estimate for the return is 30 Nov 2026 (latest 9 Dec 2026). Main reason: manufacturing problem.
Also short in United States, Canada, Italy, Spain, Switzerland, Sweden, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Docetaxel Accord 160 mg/8 ml inf. sol. (conc.) i.v. vial 8 ml | Accord Healthcare | 22 May 2026 | not given | Manufacturing problem Delay in production |
| BE | Docetaxel Accord 80 mg/4 ml inf. sol. (conc.) i.v. vial 4 ml | Accord Healthcare | 8 Jul 2026 | 9 Dec 2026 | Increased demand |
| BE | Docetaxel Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 4 ml | Eugia Pharma (Malta) | 8 Sep 2026 | 30 Nov 2026 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.